Seagen
SGEN
$228.74
Share price
-0.07%
Change (1 day)
68.92%
Change (1 year)
Categories
Seagen (SGEN) - Total assets
Total assets on the balance sheet as of September 2023 : $3.63 B
According to Seagen 's latest financial reports the company's total assets are $3.63 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Seagen - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $3.67 B | -1.21% |
| 2021-12-31 | $3.71 B | -7.03% |
| 2020-12-31 | $4.00 B | 81.38% |
| 2019-12-31 | $2.20 B | 46.73% |
| 2018-12-31 | $1.50 B | 71.23% |
| 2017-12-31 | $0.87 B | 4.72% |
| 2016-12-31 | $0.83 B | -6.33% |
| 2015-12-31 | $0.89 B | 95.02% |
| 2014-12-31 | $0.45 B | -5.15% |
| 2013-12-31 | $0.48 B | 2.65% |
| 2012-12-31 | $0.47 B | 10.87% |
| 2011-12-31 | $0.42 B | 28.88% |
| 2010-12-31 | $0.32 B | -15.04% |
| 2009-12-31 | $0.38 B | 106.87% |
| 2008-12-31 | $0.18 B | 26.38% |
| 2007-12-31 | $0.14 B | 52.03% |
| 2006-12-31 | $97.69 M | 8.53% |
| 2005-12-31 | $90.01 M | -24.42% |
| 2004-12-31 | $0.11 B | 45.26% |
| 2003-12-31 | $81.99 M | 56.08% |
| 2002-12-31 | $52.53 M | -16.65% |
| 2001-12-31 | $63.02 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 6,132.38% | 🇺🇸 USA |
 AbbVie ABBV | $134.71 B | 3,606.70% | 🇺🇸 USA |
 Biogen BIIB | $26.84 B | 638.66% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $95.15 B | 2,518.39% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | 1,966.81% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | $0.10 B | -97.04% | 🇺🇸 USA |
 ImmunoGen
IMGN | $0.82 B | -77.38% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.46 B | -87.19% | 🇺🇸 USA |